The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain
Open Access
- 20 May 2011
- journal article
- research article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 29 (7) , 767-773
Abstract
The N‐methyl‐d‐aspartate glutamate receptor (NMDAR) has been implicated in preterm brain injury (periventricular leukomalacia (PVL)) and represents a potential therapeutic target. However, the antagonist dizocilpine (MK‐801) has been reported to increase constitutive neuronal apoptosis in the developing rat brain, limiting its clinical use in the developing brain. Memantine is another use‐dependent NMDAR antagonist with shorter binding kinetics and has been demonstrated to be protective in a rat model of PVL, without effects on normal myelination or cortical growth. To further evaluate the safety of memantine in the developing brain, we demonstrate here that, in contrast to MK‐801, memantine at neuroprotective doses does not increase neuronal constitutive apoptosis. In addition, there are no long‐term alterations in the expression of NMDAR subunits, AMPAR subunits, and two markers of synaptogenesis, Synapsin‐1 and PSD95. Evaluating clinically approved drugs in preclinical neonatal animal models of early brain development is an important prerequisite to considering them for clinical trial in preterm infants and early childhood.Keywords
Funding Information
- NIH (RO1 NS31718)
- Mental Retardation Developmental Disorders Research Center (P30 HD18655)
This publication has 40 references indexed in Scilit:
- The ratio of NR2A/B NMDA receptor subunits determines the qualities of ocular dominance plasticity in visual cortexProceedings of the National Academy of Sciences, 2009
- Brain injury in premature infants: a complex amalgam of destructive and developmental disturbancesThe Lancet Neurology, 2009
- Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticityNeuropharmacology, 2008
- NMDA Receptor Blockade with Memantine Attenuates White Matter Injury in a Rat Model of Periventricular LeukomalaciaThe Journal of Neuroscience, 2008
- GABA Regulates Excitatory Synapse Formation in the Neocortex via NMDA Receptor ActivationThe Journal of Neuroscience, 2008
- The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cellsNeurochemistry International, 2008
- Developmental regulation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortexJournal of Comparative Neurology, 2006
- Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal culturesBrain Research, 2006
- Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brainBritish Journal of Pharmacology, 2005
- Quantitative growth and development of human brainArchives of Disease in Childhood, 1973